Proteomics International Laboratories Ltd (PIQ.AX) Webinar and Q&A

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to invite shareholders, investors and interested parties to an online update on the recent announcement regarding the application for PromarkerD's listing on the Australian Medicare Benefits Schedule hosted by MD, Dr Richard Lipscombe.

The webinar will be held on Friday, 17 March 11:30am AEDT (8.30am AWST).

For the Q&A session, investors are invited to send questions for the webinar prior to 9:30am AEDT (6:30am WST) Friday 17th March to: dirk@candouradvisory.com.au

Register for the webinar at the link below:
https://ccmediaframe.com/?id=lYS2LHSd

After registering, you will receive a confirmation email containing information about joining.

Dr Richard Lipscombe
Managing Director
Proteomics International Laboratories Ltd
T: +61 8 9389 1992
E: enquiries@proteomicsinternational.com

Dirk van Dissel 
Investor Relations & Corporate Advisor
Candour Advisory
T: +61 408 326 367 
E: dirk@candouradvisory.com.au

Kyle Moss
Corporate Advisor
Euroz Hartleys
T: +61 8 9488 1400
E: kmoss@eurozhartleys.com

News Provided by ABN Newswire